Actively Recruiting
Biomarkers for Risk Stratification in Lung Cancer
Led by University of California, San Francisco · Updated on 2025-03-20
590
Participants Needed
3
Research Sites
419 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
N
Northern California Institute of Research and Education
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of two primary populations to determine the ctDNA assay performance in a variety of clinical settings.
CONDITIONS
Official Title
Biomarkers for Risk Stratification in Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 240 years
- Ability to understand and provide written informed consent
- Willingness to comply with study protocols and provide blood samples
- Willingness to complete 3-year clinical follow up
You will not qualify if you...
- Active non-cutaneous malignancy within the past 5 years
- Anemia with hematocrit less than 30% after first blood draw
- Malnourishment with BMI less than 19 or albumin level less than 2.5 mg/dL if history of malnourishment
- Severe Chronic Obstructive Pulmonary Disease (COPD) defined as Gold Stage IV
- Unstable heart conditions including stable or unstable angina, recent myocardial infarction within 2 years, active congestive heart failure, ischemic cardiomyopathy, or complications from prior blood donation
- Liver cirrhosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California, United States, 94110
Actively Recruiting
2
San Francisco VA Medical Center
San Francisco, California, United States, 94121
Actively Recruiting
3
University of California, San Francisco
San Francisco, California, United States, 94122
Actively Recruiting
Research Team
M
Mehrdad Arjomandi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here